Ian Somaiya


BMO Weighs in on Celgene Corporation (CELG) Ahead of Mongersen Phase 2 Data

BMO believes Mongersen has the potential to achieve $4 billion in revenue

Analysts Provide Insight on Celgene Corporation (CELG) And Receptos Inc (RCPT) in Light of Acquisition Announcement

Oncology therapy company Celgene Corporation (NASDAQ:CELG) announced a definitive agreement on July 14 to acquire Receptos Inc (NASDAQ: RCPT). Under the terms of …

Nomura Holdings Maintains Buy on Amgen Inc. Following FDA Panel Recommendation for Repatha

Nomura Holdings analyst Ian Somaiya came out with some commentary on Amgen Inc. (NASDAQ:AMGN) following an FDA panel recommendation for the company’s drug Repatha, …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts